Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response

Area of Science:

• Endocrinology
• Metabolic Syndrome Research
• Diabetes Pathophysiology

Background:

• Metabolic syndrome is linked to renin-angiotensin system activation.
• Angiotensin II (AngII) contributes to beta-cell dysfunction and inflammation, potentially initiating type 2 diabetes.
• Understanding AngII's mechanism in beta-cell dysfunction is crucial for diabetes prevention.

Purpose of the Study:

• To investigate the mechanisms by which AngII induces beta-cell dysfunction.
• To determine the role of endoplasmic reticulum (ER) stress in AngII-mediated beta-cell damage.
• To evaluate the protective effects of taurine-conjugated ursodeoxycholic acid (TUDCA) against AngII-induced beta-cell dysfunction.

Main Methods:

• Islets of Langerhans were isolated from C57BL/6J mice.
• Mice were infused with AngII, with or without TUDCA.
• Effects on ER stress, inflammation, and beta-cell function were assessed in vivo and ex vivo.
• Studies utilized isolated murine islets and clonal beta cells.

Main Results:

• AngII induced ER stress, increased proinflammatory cytokine mRNA expression, and caused beta-cell dysfunction.
• TUDCA significantly attenuated these AngII-induced effects.
• AngII-induced ER stress was dependent on reactive oxygen species and IP3 receptor activation.
• ER stress was essential for increased proinflammatory cytokine expression.

Conclusions:

• ER stress induction is critical for AngII-mediated beta-cell dysfunction.
• AngII promotes beta-cell inflammation and dysfunction via ER stress, reactive oxygen species, and IP3 receptor activation.
• Therapies promoting ER homeostasis may offer a strategy for type 2 diabetes prevention.